Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)An EEG Study of Intravenous Ketamine for Major Depression Disorder
- First Posted Date
- 2022-08-18
- Last Posted Date
- 2022-08-22
- Lead Sponsor
- Ehave Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT05506462
News
No news found